Dr. Reddy's Laboratories Limited RDY
Set alert
14.13 USD -0.04 -0.28%
At close
14.20 +0.07 +0.50%
Pre-market · Nov 3, 6:14 AM ET
14.05 Day range 14.20
11.36 52-week range 15.67
- YTD
- +0.64%
- 1 year
- +6.32%
- Open
- 14.15
- Prev close
- 14.17
- Mkt cap
- 11.77B
- Vol
- 1.93M
- Avg vol
- 2.92M
- EPS
- 0.36
- P/E
- 39.25
- Div yield
- 0.46%
More statistics
- Low
- 14.05
- High
- 14.20
- Forward P/E
- 21.33
- Beta
- 0.20
- Short ratio
- 8.16
- Inst. own
- 14.92%
- Dividend
- 0.08
- Ex-div date
- Jul 8, 2026
- Earnings
- Jan 22, 2027
- 50-d avg
- 12.54
- 200-d avg
- 13.21
- 1y target
- 14.32
5D chart
Signals (54)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 9:30 AM | 20 hours ago |
| MACD: Sell Signal | Nov 2, 9:30 AM | 20 hours ago |
| MACD: Buy Signal | Oct 30, 3:50 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:45 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:35 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:30 PM | 3 days ago |
| RSI: Oversold | Oct 30, 3:10 PM | 3 days ago |
| RSI: Oversold | Oct 30, 3:00 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:20 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:10 PM | 3 days ago |
| RSI: Overbought | Oct 30, 1:50 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 12:45 PM | 3 days ago |
| SMA: Bullish | Oct 30, 10:40 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:35 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 10:30 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:15 AM | 3 days ago |
| SMA: Bullish | Oct 30, 9:30 AM | 3 days ago |
| SMA: Bullish | Oct 30, 9:30 AM | 3 days ago |
| RSI: Overbought | Oct 30, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 29, 3:45 PM | 4 days ago |
Newest 20 of 54.
Analyst view
Consensus: buy
Buy
Price target (mean) 14.32 +1.3% upside
Now 14.13
- Target (low)
- 12.51
- Target (mean)
- 14.32
- Target (high)
- 15.71
Ratings (0m) 5 3 buy · 2 hold · 0 sell
- Strong buy1
- Buy2
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 90.49B | +3.7% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 90.86B | +20.9% | 0 |
| Current year | 46.22 | 43.73 – 48.70 | 55.39 | -16.6% | 351.28B | +4.6% | 2 |
| Next year | 62.49 | 59.86 – 65.12 | 46.22 | +35.2% | 393.17B | +11.9% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 29, 2026 | Citigroup | Upgrade | Sell | Buy |
| Jun 5, 2025 | HSBC | Upgrade | Hold | Buy |
| Nov 6, 2024 | Barclays | Maintained | Overweight | Overweight |
| Jul 30, 2024 | Barclays | Maintained | Overweight | Overweight |
| May 8, 2024 | Barclays | Maintained | Overweight | Overweight |
| Jan 29, 2024 | Barclays | Maintained | Overweight | Overweight |
| Jun 1, 2023 | Barclays | Maintained | Overweight | Overweight |
| Oct 31, 2022 | Barclays | Maintained | — | Overweight |
| Oct 25, 2022 | Barclays | Maintained | — | Overweight |
| Sep 12, 2022 | Barclays | Maintained | — | Overweight |
| Jul 25, 2022 | Barclays | Maintained | — | Overweight |
| May 24, 2022 | Barclays | Maintained | — | Overweight |
| Nov 1, 2021 | Barclays | Maintained | — | Overweight |
| Feb 2, 2021 | Barclays | Upgrade | Equal-Weight | Overweight |
| Jan 28, 2020 | CLSA | Downgrade | Buy | Outperform |
| Jan 9, 2020 | Citigroup | Upgrade | Sell | Buy |
| Nov 4, 2019 | B of A Securities | Downgrade | Buy | Neutral |
| Sep 4, 2019 | Credit Suisse | Upgrade | Underperform | Outperform |
| Jun 11, 2019 | Barclays | Initiated | — | Equal-Weight |
| May 20, 2019 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Nov 1, 2017 | Jefferies | Maintained | — | Underperform |
| Sep 21, 2017 | Morgan Stanley | Upgrade | Equal-Weight | Overweight |
| Jul 27, 2016 | HSBC | Downgrade | Hold | Reduce |
| Jul 27, 2016 | Jefferies | Downgrade | Hold | Underperform |
| Jul 26, 2016 | Credit Suisse | Downgrade | Neutral | Underweight |
| May 2, 2016 | Goldman Sachs | Initiated | — | Neutral |
| Feb 10, 2016 | CLSA | Upgrade | Underperform | Buy |
| Dec 2, 2015 | Deutsche Bank | Initiated | — | Sell |
| Feb 15, 2013 | B of A Securities | Downgrade | Buy | Neutral |
| Dec 12, 2012 | Credit Suisse | Upgrade | Neutral | Outperform |